Containing Ebola And Controversy Over An Experimental Drug
Jack Kearse/Emory University via Getty Images
Nearly a thousand people have died from Ebola since the latest outbreak of the virus began. Last week the World Health Organization declared an international public health emergency. Two Americans who contracted Ebola while working in Africa were flown back to the U.S. under tight security and given an experimental drug. Their health improved. But doctors do not yet know if the drug - called ZMapp - had any effect. The treatment of two white Americans when hundreds of Africans are fighting for their lives has spurred intense debate. Diane and guests give an update on the epidemic and discuss the ethics of experimental drugs to treat Ebola.
director, U.S. Centers for Disease Control and Prevention.
director, National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
director, Pellegrino Center for Clinical Bioethics at Georgetown University Medical Center.